6-Shogaol, a ginger product, modulates neuroinflammation: A new approach to neuroprotection

Neuropharmacology

Volumn 63, Issue 2, 2012, Pages 211-223

  Ha, Sang Keun ^a,b   Moon, Eunjung ^a   Ju, Mi Sun ^a   Kim, Dong Hyun ^a   Ryu, Jong Hoon ^a   Oh, Myung Sook ^a   Kim, Sun Yeou ^a  

^a Kyung Hee University   (South Korea)

^b Korea Food Research Institute   (South Korea)

Author keywords

Ginger; Ischemia; Microglia; Neuroprotection; Shogaol

Indexed keywords

(6) GINGEROL; 6 SHOGAOL; ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; N(G) METHYLARGININE; NITRIC OXIDE; PLANT MEDICINAL PRODUCT; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; WOGONIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN ISCHEMIA; CELL ACTIVATION; CELL CULTURE; CELL DEATH; CONTROLLED STUDY; DEGENERATIVE DISEASE; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVATION; ENZYME INHIBITION; GINGER; IN VITRO STUDY; IN VIVO STUDY; MALE; MICROGLIA; MORNING DOSAGE; MOUSE; NERVE CELL; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BRAIN ISCHEMIA; CATECHOLS; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOKINES; DINOPROSTONE; DOWN-REGULATION; ENCEPHALITIS; INFLAMMATION MEDIATORS; MALE; MICE; MICROGLIA; NEURONS; NEUROPROTECTIVE AGENTS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PLANT EXTRACTS; RATS, SPRAGUE-DAWLEY;

EID: 84861975965     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2012.03.016     Document Type: Article

References (71)

1. Ahn, S.I., Lee, J.K., Youn, H.S., 2009. Inhibition of homodimerization of toll-like receptor 4 by 6-shogaol. Mol. Cell. 27, 211-215.
2. Aisen, P.S., Schafer, K.A., Grundman, M., Pfeiffer, E., Sano, M., Davis, K.L., Farlow, M.R., Jin, S., Thomas, R.G., Thal, L.J., 2003. Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial. J. Am. Med. Assoc. 289, 2819-2826.
3. Ali, B.H., Blunden, G., Tanira, M.O., Nemmar, A., 2008. Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): a review of recent research. Food. Chem. Toxicol. 46, 409-420.
4. Aloisi, F., 1999. The role of microglia and astrocytes in CNS immune surveillance and immunopathology. Adv. Exp. Med. Biol. 468, 123-133.
5. Baeuerle, P.A., Baltimore, D., 1988. I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science 242, 540-546.
6. Baeuerle, P.A., Henkel, T., 1994. Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 12, 141-179.
7. Banati, R.B., Gehrmann, J., Schubert, P., Kreutzberg, G.W., 1993. Cytotoxicity of microglia. Glia 7, 111-118.
8. Barone, F.C., Feuerstein, G.Z., 1999. Inflammatory mediators and stroke: new opportunities for novel therapeutics. J. Cereb. Blood. Flow. Metab. 19, 819-834.
9. Bhat, N.R., Zhang, P., Lee, J.C., Hogan, E.L., 1998. Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures. J. Neurosci. 18, 1633-1641.
10. Blasi, E., Barluzzi, R., Bocchini, V., Mazzolla, R., Bistoni, F., 1990. Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus. J. Neuroimmunol. 27, 229-237.
11. Boje, K.M., Arora, P.K., 1992. Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain. Res. 587, 250-256.
12. Bronstein, D.M., Perez-Otano, I., Sun, V., Mullis Sawin, S.B., Chan, J., Wu, G.C., Hudson, P.M., Kong, L.Y., Hong, J.S., McMillian, M.K., 1995. Glia-dependent neurotoxicity and neuroprotection in mesencephalic cultures. Brain. Res. 704, 112-116.
13. Campbell, A., 2004. Inflammation, neurodegenerative diseases, and environmental exposures. Ann. N. Y. Acad. Sci. 1035, 117-132.
14. Candelario-Jalil, E., Gonzalez-Falcon, A., Garcia-Cabrera, M., Alvarez, D., Al-Dalain, S., Martinez, G., Leon, O.S., Springer, J.E., 2003. Assessment of the relative contribution of COX-1 and COX-2 isoforms to ischemia-induced oxidative damage and neurodegeneration following transient global cerebral ischemia. J. Neurochem. 86, 545-555.
15. Carter, A.B., Knudtson, K.L., Monick, M.M., Hunninghake, G.W., 1999. The p38 mitogen-activated protein kinase is required for NF-kappaB-dependent gene expression. The role of TATA-binding protein (TBP). J. Biol. Chem. 274, 30858-30863.
16. Chao, C.C., Hu, S., Molitor, T.W., Shaskan, E.G., Peterson, P.K., 1992. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J. Immunol. 149, 2736-2741.
17. Chen, Y.C., Shen, S.C., Chen, L.G., Lee, T.J., Yang, L.L., 2001. Wogonin, baicalin, and baicalein inhibition of inducible nitric oxide synthase and cyclooxygenase-2 gene expressions induced by nitric oxide synthase inhibitors and lipopolysaccharide. Biochem. Pharmacol. 61, 1417-1427.
18. Cho, K.O., Kim, S.K., Cho, Y.J., Sung, K.W., Kim, S.Y., 2007. Regional differences in the neuroprotective effect of minocycline in a mouse model of global forebrain ischemia. Life. Sci. 80, 2030-2035.
19. Chrubasik, S., Pittler, M.H., Roufogalis, B.D., 2005. Zingiberis rhizoma: a comprehensive review on the ginger effect and efficacy profiles. Phytomedicine 12, 684-701.
20. del Zoppo, G., Ginis, I., Hallenbeck, J.M., Iadecola, C., Wang, X., Feuerstein, G.Z., 2000. Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia. Brain. Pathol. 10, 95-112.
21. Dickson, D.W., Lee, S.C., Mattiace, L.A., Yen, S.H., Brosnan, C., 1993. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 7, 75-83.
22. Dirnagl, U., Iadecola, C., Moskowitz, M.A., 1999. Pathobiology of ischaemic stroke: an integrated view. Trends. Neurosci. 22, 391-397.
23. Fan, R., Xu, F., Previti, M.L., Davis, J., Grande, A.M., Robinson, J.K., Van Nostrand, W.E., 2007. Minocycline reduces microglial activation and improves behavioral deficits in a transgenic model of cerebral microvascular amyloid. J. Neurosci. 27, 3057-3063.
24. Giulian, D., Vaca, K., 1993. Inflammatory glia mediate delayed neuronal damage after ischemia in the central nervous system. Stroke 24, I84-I90.
25. Grzanna, R., Lindmark, L., Frondoza, C.G., 2005. Gingerean herbal medicinal product with broad anti-inflammatory actions. J. Med. Food. 8, 125-132.
26. Ha, S.K., Lee, P., Park, J.A., Oh, H.R., Lee, S.Y., Park, J.H., Lee, E.H., Ryu, J.H., Lee, K.R., Kim, S.Y., 2008. Apigenin inhibits the production of NO and PGE2 in microglia and inhibits neuronal cell death in a middle cerebral artery occlusion-induced focal ischemia mice model. Neurochem. Int. 52, 878-886.
27. Hanada, T., Yoshimura, A., 2002. Regulation of cytokine signaling and inflammation. Cytokine. Growth. Factor. Rev. 13, 413-421.
28. Heneka, M.T., Feinstein, D.L., 2001. Expression and function of inducible nitric oxide synthase in neurons. J. Neuroimmunol. 114, 8-18.
29. Henry, C.J., Huang, Y., Wynne, A., Hanke, M., Himler, J., Bailey, M.T., Sheridan, J.F., Godbout, J.P., 2008. Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia. J. Neuroinflammation 5, 15.
30. Hunot, S., Boissiere, F., Faucheux, B., Brugg, B., Mouatt-Prigent, A., Agid, Y., Hirsch, E.C., 1996. Nitric oxide synthase and neuronal vulnerability in Parkinson's disease. Neuroscience 72, 355-363.
31. Jeohn, G.H., Kong, L.Y., Wilson, B., Hudson, P., Hong, J.S., 1998. Synergistic neurotoxic effects of combined treatments with cytokines in murine primary mixed neuron/glia cultures. J. Neuroimmunol. 85, 1-10.
32. Jolad, S.D., Lantz, R.C., Solyom, A.M., Chen, G.J., Bates, R.B., Timmermann, B.N., 2004. Fresh organically grown ginger (Zingiber officinale): composition and effects on LPS-induced PGE2 production. Phytochemistry 65, 1937-1954.
33. Jung, H.W., Yoon, C.H., Park, K.M., Han, H.S., Park, Y.K., 2009. Hexane fraction of Zingiberis Rhizoma Crudus extract inhibits the production of nitric oxide and proinflammatory cytokines in LPS-stimulated BV2 microglial cells via the NF-kappaB pathway. Food. Chem. Toxicol. 47, 1190-1197.
34. Kaminska, B., 2005. MAPK signalling pathways as molecular targets for anti-inflammatory therapyefrom molecular mechanisms to therapeutic benefits. Biochim. Biophys. Acta. 1754, 253-262.
35. Karin, M., Yamamoto, Y., Wang, Q.M., 2004. The IKK NF-kappa B system: a treasure trove for drug development. Nat. Rev. Drug. Discov. 3, 17-26.
36. Kim, Y.S., Joh, T.H., 2006. Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease. Exp. Mol. Med. 38, 333-347.
37. Kitagawa, K., Matsumoto, M., Oda, T., Niinobe, M., Hata, R., Handa, N., Fukunaga, R., Isaka, Y., Kimura, K., Maeda, H., et al., 1990. Free radical generation during brief period of cerebral ischemia may trigger delayed neuronal death. Neuroscience 35, 551-558.
38. Klivenyi, P., Gardian, G., Calingasan, N.Y., Yang, L., Beal, M.F., 2003. Additive neuroprotective effects of creatine and a cyclooxygenase 2 inhibitor against dopamine depletion in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease. J. Mol. Neurosci. 21, 191-198.
39. Kreutzberg, G.W., 1996. Microglia: a sensor for pathological events in the CNS. Trends. Neurosci. 19, 312-318.
40. Lee, H., Kim, Y.O., Kim, H., Kim, S.Y., Noh, H.S., Kang, S.S., Cho, G.J., Choi, W.S., Suk, K., 2003. Flavonoid wogonin from medicinal herb is neuroprotective by inhibiting inflammatory activation of microglia. FASEB. J. 17, 1943-1944.
41. Lee, H.S., Jung, K.K., Cho, J.Y., Rhee, M.H., Hong, S., Kwon, M., Kim, S.H., Kang, S.Y., 2007. Neuroprotective effect of curcumin is mainly mediated by blockade of microglial cell activation. Pharmazie 62, 937-942.
42. Liu, B., Hong, J.S., 2003. Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J. Pharmacol. Exp. Ther. 304, 1-7.
43. Marcocci, L., Maguire, J.J., Droy-Lefaix, M.T., Packer, L., 1994. The nitric oxide-scavenging properties of Ginkgo biloba extract EGb 761. Biochem. Biophys. Res. Commun. 201, 748-755.
44. McGeer, P.L., McGeer, E.G., 1995. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain. Res. Brain. Res. Rev. 21, 195-218.
45. McGeer, P.L., McGeer, E.G., 2004. Inflammation and neurodegeneration in Parkinson's disease. Parkinsonism. Relat. Disord. 10 (Suppl. 1), S3-S7.
46. McGeer, P.L., Itagaki, S., Boyes, B.E., McGeer, E.G., 1988. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38, 1285-1291.
47. Meyer, C.F., Wang, X., Chang, C., Templeton, D., Tan, T.H.,1996. Interaction between c-Rel and the mitogen-activated protein kinase kinase kinase 1 signaling cascade in mediating kappaB enhancer activation. J. Biol. Chem. 271, 8971-8976.
48. Minghetti, L., Levi, G., 1998. Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide. Prog. Neurobiol. 54, 99-125.
49. Murphy, S., 2000. Production of nitric oxide by glial cells: regulation and potential roles in the CNS. Glia 29, 1-13.
50. Nakayama, M., Uchimura, K., Zhu, R.L., Nagayama, T., Rose, M.E., Stetler, R.A., Isakson, P.C., Chen, J., Graham, S.H., 1998. Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia. Proc. Natl. Acad. Sci. U S A 95, 10954-10959.
51. Nogawa, S., Zhang, F., Ross, M.E., Iadecola, C., 1997. Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage. J. Neurosci. 17, 2746-2755.
52. Nomura, Y., 2001. NF-kappaB activation and IkappaB alpha dynamism involved in iNOS and chemokine induction in astroglial cells. Life. Sci. 68, 1695-1701.
53. Pan, M.H., Hsieh, M.C., Hsu, P.C., Ho, S.Y., Lai, C.S., Wu, H., Sang, S., Ho, C.T., 2008. 6- Shogaol suppressed lipopolysaccharide-induced up-expression of iNOS and COX-2 in murine macrophages. Mol. Nutr. Food. Res. 52, 1467-1477.
54. Planas, A.M., Soriano, M.A., Rodriguez-Farre, E., Ferrer, I., 1995. Induction of cyclooxygenase-2 mRNA and protein following transient focal ischemia in the rat brain. Neurosci. Lett. 200, 187-190.
55. Qin, L., Liu, Y., Cooper, C., Liu, B., Wilson, B., Hong, J.S., 2002. Microglia enhance beta-amyloid peptide-induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species. J. Neurochem. 83, 973-983.
56. Raine, C.S., 1994. Multiple sclerosis: immune system molecule expression in the central nervous system. J. Neuropathol. Exp. Neurol. 53, 328-337.
57. Rollinger, J.M., Langer, T., Stuppner, H., 2006. Strategies for efficient lead structure discovery from natural products. Curr. Med. Chem. 13, 1491-1507.
58. Shukla, Y., Singh, M., 2007. Cancer preventive properties of ginger: a brief review. Food. Chem. Toxicol. 45, 683-690.
59. Stoll, G., Jander, S., Schroeter, M., 1998. Inflammation and glial responses in ischemic brain lesions. Prog. Neurobiol. 56, 149-171.
60. Suekawa, M., Ishige, A., Yuasa, K., Sudo, K., Aburada, M., Hosoya, E., 1984. Pharmacological studies on ginger. I. Pharmacological actions of pungent constitutents, (6)-gingerol and (6)-shogaol. J. Pharmacobiodyn 7, 836-848.
61. Teismann, P., Vila, M., Choi, D.K., Tieu, K., Wu, D.C., Jackson-Lewis, V., Przedborski, S., 2003. COX-2 and neurodegeneration in Parkinson's disease. Ann. N. Y. Acad. Sci. 991, 272-277.
62. Tocco, G., Freire-Moar, J., Schreiber, S.S., Sakhi, S.H., Aisen, P.S., Pasinetti, G.M., 1997. Maturational regulation and regional induction of cyclooxygenase-2 in rat brain: implications for Alzheimer's disease. Exp. Neurol. 144, 339-349.
63. Tripathi, S., Maier, K.G., Bruch, D., Kittur, D.S., 2007. Effect of 6-gingerol on proinflammatory cytokine production and costimulatory molecule expression in murine peritoneal macrophages. J. Surg. Res. 138, 209-213.
64. Waetzig, V., Czeloth, K., Hidding, U., Mielke, K., Kanzow, M., Brecht, S., Goetz, M., Lucius, R., Herdegen, T., Hanisch, U.K., 2005. c-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia. Glia 50, 235-246.
65. Xie, Z., Wei, M., Morgan, T.E., Fabrizio, P., Han, D., Finch, C.E., Longo, V.D., 2002. Peroxynitrite mediates neurotoxicity of amyloid beta-peptide1-42- and lipopolysaccharide-activated microglia. J. Neurosci. 22, 3484-3492.
66. Xie, Z., Smith, C.J., Van Eldik, L.J., 2004. Activated glia induce neuron death via MAP kinase signaling pathways involving JNK and p38. Glia 45, 170-179.
67. Yamamoto, T., Yuki, S., Watanabe, T., Mitsuka, M., Saito, K.I., Kogure, K., 1997. Delayed neuronal death prevented by inhibition of increased hydroxyl radical formation in a transient cerebral ischemia. Brain. Res. 762, 240-242.
68. Yang, S., Zhang, D., Yang, Z., Hu, X., Qian, S., Liu, J., Wilson, B., Block, M., Hong, J.S., 2008. Curcumin protects dopaminergic neuron against LPS induced neurotoxicity in primary rat neuron/glia culture. Neurochem. Res. 33, 2044-2053.
69. Yrjanheikki, J., Keinanen, R., Pellikka, M., Hokfelt, T., Koistinaho, J., 1998. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc. Natl. Acad. Sci. U S A 95, 15769-15774.
70. Yrjanheikki, J., Tikka, T., Keinanen, R., Goldsteins, G., Chan, P.H., Koistinaho, J., 1999. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc. Natl. Acad. Sci. U S A 96, 13496-13500.
71. Zandi, E., Rothwarf, D.M., Delhase, M., Hayakawa, M., Karin, M., 1997. The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell 91, 243-252.